Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 13, 2009, Pages 5192-5197

  Susaki, Etsuo ^a,b   Nakayama, Keiko ^b,c   Yamasaki, Lili ^d   Nakayama, Keiichi I ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cell cycle; Development; Genetics

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27; PROTEIN P57; TRANSCRIPTION FACTOR E2F1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASE INHIBITOR P57; E2F1 TRANSCRIPTION FACTOR; GENE KNOCK-IN TECHNIQUES; GROWTH AND DEVELOPMENT; MICE; MICE, KNOCKOUT; PHENOTYPE;

MUS;

EID: 65249113847     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0811712106     Document Type: Article

References (54)

1. Sherr CJ, Roberts JM (1999) CDK inhibitors: Positive and negative regulators of G1- phase progression. Genes Dev 13:1501-1512.
2. Nakayama KI, NakayamaK(1998) Cip/Kip cyclin-dependent kinase inhibitors: Brakes of the cell cycle engine during development. BioEssays 20:1020-1029.
3. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639-649.
4. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662.
5. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22.
6. Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
7. Hengst L, Dulic V, Slingerland JM, Lees E, Reed SI (1994) Acell cycle-regulated inhibitor of cyclin-dependent kinases. Proc Natl Acad Sci USA 91:5291-5295.
8. Nourse J, et al. (1994) Interleukin-2 mediated elimination of the p27(Kip1) cyclindependent kinase inhibitor prevented by rapamycin. Nature 372:570-573.
9. Reynisdottir I, Polyak K, Iavarone A, Massague J (1995) Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev 9:1831-1845.
10. Skp2-dependent ubiquitylation. Proc Natl Acad Sci USA 100:10231-10236.
11. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
12. Kip1- deficient mice. Cell 85:733-744.
13. Kip1. Cell 85:721-732.
14. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720.
15. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 11:973-983.
16. Kip2, exhibit skeletal abnormalities and growth retardation. J Biochem 127:73-83.
17. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158.
18. Kip2 during mouse development. Anat Embryol 203:77-87.
19. Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem 278:52919-52923.
20. Laman H, et al. (2005) Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. EMBO J 24:3104-3116.
21. Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 18:862-876.
22. kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 20:1511-1524.
23. 2-terminal kinase/stress-activated protein kinase. J Biol Chem 278:48092-48098.
24. KIP2 by interacting with its cyclin-binding domain. J Biol Chem 278:44255-44264.
25. Kip2 cooperateswith Nurr1 in developing dopamine cells. Proc Natl Acad Sci USA 100:15619-15624.
26. Kip2. J Biol Chem 275:18767-18776.
27. KIP2 requires binding to proliferating cell nuclear antigen. Proc Natl Acad Sci USA 95:1392-1397.
28. Morgenbesser SD, Williams BO, Jacks T, DePinho RA (1994) p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-74.
29. Cobrinik D, etal. (1996) Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 10:1633-1644.
30. Putzer BM (2007) E2F1 death pathways as targets for cancer therapy. J Cell Mol Med 11:239-251.
31. Hsiao KM, McMahon SL, Farnham PJ (1994) Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter. Genes Dev 8:1526-1537.
32. Neuman E, Flemington EK, Sellers WR, Kaelin WG, Jr (1994) Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 14:6607-6615.
33. Degregori J, Leone G, Miron A, Jakoi L, Nevins JR (1997) Distinct roles for E2F proteins in cell growth control and apoptosis. Proc Natl Acad Sci USA 94:7245-7250.
34. Kip1 at G1 phase. Nat Cell Biol 6:1229-1235.
35. Kip1. Cancer Res 67:10789-10795.
36. Koufos A, et al. (1989) Familial Wiedemann-Beckwith syndrome and a second Wilms tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719.
37. Ping AJ, et al. (1989) Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet 44:720-723.
38. KIP2 targeted disruption and Beckwith-Wiedemann syndrome: Is the inhibitor just a contributor? BioEssays 19:839-842.
39. Kip2 and Igf2 interact ina mouse model for Beckwith-Wiedemann syndrome. Genes Dev 13:3115-3124.
40. Kip1 in the acute promyelocytic leukemia cell line NB4. Blood 107:1133-1140.
41. Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 128:269-280.
42. Chu I, etal. (2007) p27 phosphorylationby src regulates inhibitionof cyclin E-Cdk2. Cell 128:281-294.
43. Kip1 controls its cyclin D-cdk4 inhibitory activity. Mol Cell Biol 28:498-510.
44. Nakanishi M, Kaneko Y, Matsushime H, Ikeda K (1999) Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein. Biochem Biophys Res Commun 263:35-40.
45. Kip1 acts downstream ofN-cadherin-mediated cell adhesion to promote myogenesis beyond cell cycle regulation. Mol Biol Cell 16:1469-1480.
46. kip1 contributing to actin organization and cortical neuronal migration. Nat Cell Biol 8:17-26.
47. Kip2 in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci 27:6185-6196.
48. Kip2 regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development 127:3593-3605.
49. Kip2 stabilizes the MyoD protein byinhibiting cyclin E-Cdk2 kinase activityingrowing myoblasts. Mol Cell Biol 19:7621-7629.
50. Takahashi H, Koshimizu U, Miyazaki J-I, Nakamura T (2002) Impaired spermatogenic ability of testicular germ cells in mice deficient in the LIM-kinase 2 gene. Dev Biol 241:259-272.
51. KIP2 proteolysis regulates osteoblast cell differentiation. EMBO Rep 9:878-884.
52. Taniguchi M, et al. (1998) Efficient production of Cre-mediated site-directed recombinants through the utilization of the puromycin resistance gene, pac: A transient gene-integration marker for ES cells. Nucleic Acids Res 26:679-680.
53. Onoyama I, et al. (2007) Conditional inactivation of Fbxw 7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 204:2875-2888.
54. David G, et al. (2008) Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proc Natl Acad Sci USA 105:4168-4172.